In the context of real-world evidence, a registry is a collection of data on a particular disease, medical condition, or treatment that is recorded over time. A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention.
A registry is typically created to collect data on a particular population, such as patients with a specific medical condition or those who have been treated with a particular medication. The data collected in a registry may be observational or experimental, and can include demographic information, medical history, treatment information, and outcomes.
A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention. In a registry-based study, researchers analyze the data collected in a registry to answer specific research questions, such as whether a particular treatment is effective in improving patient outcomes, or whether there are any safety concerns associated with a specific medication.
The main difference between a registry and a registry-based study is that a registry is a database of information, while a registry-based study is a research study that uses data from a registry. Registries can be used for a variety of purposes, including monitoring the safety and effectiveness of treatments, tracking disease incidence and prevalence, and identifying gaps in care. Registry-based studies are one way to use the data collected in a registry to generate new knowledge and insights about a particular disease or treatment.
Overall, both registries and registry-based studies are important tools for collecting and analyzing real-world evidence, and can provide valuable information to healthcare providers, patients, and researchers about the safety and effectiveness of medical interventions.
Share this story...
Real World Evidence (RWE) – TMF Reference Model versus the Real-World Study Document Index (RWS-DI)
RWE 101 - TMF Reference Model versus the Real-World Study Document Index (RWS-DI) The Real World Study-Document Index (RWS-DI) is a framework developed by a working group of RWE [...]
Real World Evidence (RWE) 101 – ISF vs TMF
RWE 101 - ISF vs TMF Investigator Site File (ISF) and Trial (Study) Master File (TMF) are key elements in managing clinical and observational studies. They are distinct but [...]
Real World Evidence (RWE) 101 – Study Conduct
RWE 101 - Study Conduct Once the study has been set up, the study conduct phase begins. This phase includes several key activities that ensure the smooth running of [...]
Real World Evidence (RWE) 101 – Monitoring
RWE 101 - Monitoring Monitoring requirements for Real-World Evidence (RWE) studies may differ from those of traditional randomized controlled trials due to the nature of data collection and the [...]
Real World Evidence (RWE) 101 – eConsent
RWE 101 - eConsent Electronic consent or eConsent refers to the process of using electronic systems and processes to convey information related to the study and to obtain and [...]
Real World Evidence (RWE) 101 – Consent to Participate in Research vs Consent to Access and Process Sensitive Healthcare Data (GDPR)
RWE 101 - Consent to Participate in Research vs Consent to Access and Process Sensitive Healthcare Data (GDPR) Consent to participate in research and consent to access and process [...]







